These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 6328452)

  • 1. Red blood cell labelling by intravenous injection of 99mTc-PAEP.
    Varvarigou A; Chiotellis E; Vavouraki H
    Nuklearmedizin; 1984 Feb; 23(1):29-30. PubMed ID: 6328452
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [In vivo labeling of erythrocytes with radiotechnetium after premedication with phytate].
    Bałtrukiewicz Z; Popowska E; Przedlacki J
    Pol Przegl Radiol Med Nukl; 1982; 46(4):175-7. PubMed ID: 6302643
    [No Abstract]   [Full Text] [Related]  

  • 3. Technical parameters of in vivo red blood cell labeling with Technetium-99m.
    Zimmer AM; Pavel DG; Karesh SM
    Nuklearmedizin; 1979 Dec; 18(5):241-5. PubMed ID: 547251
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo labeling of red blood cells with Tc-99m with stannous pyridoxylideneaminates.
    Kato M
    J Nucl Med; 1979 Oct; 20(10):1071-4. PubMed ID: 536758
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of modified technetium-99m albumin and technetium-99m red blood cells for equilibrium ventriculography.
    Hambÿe AS; Verbeke KA; Vandermeiren RP; Joosens EJ; Verbruggen AM; De Roo MJ
    J Nucl Med; 1997 Oct; 38(10):1521-8. PubMed ID: 9379186
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A modified method for the in vivo labeling of red blood cells with Tc-99m: concise communication.
    Callahan RJ; Froelich JW; McKusick KA; Leppo J; Strauss HW
    J Nucl Med; 1982 Apr; 23(4):315-8. PubMed ID: 6279801
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of preloading of stannous compounds on the distribution of 99mTc-pertechnetate.
    Greenberg DD; Som P; Meinken GE; Sacker DF; Atkins HL
    Nuklearmedizin; 1977 Feb; 16(1):26-9. PubMed ID: 191793
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of [99mTc]N-phosphorylaminoethyl-phosphate [( 99mTc]PAEP) as imaging agent in acute myocardial infarction.
    Chiotellis E; Varvarigou A; Smirniotis B; Papadimitriou J
    Int J Nucl Med Biol; 1984; 11(3-4):280-2. PubMed ID: 6099342
    [No Abstract]   [Full Text] [Related]  

  • 9. In vivo labeling of red blood cells with 99mTc: a new approach to blood pool visualization.
    Pavel DG; Zimmer M; Patterson VN
    J Nucl Med; 1977 Mar; 18(3):305-8. PubMed ID: 839281
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 99mTc-labelled compounds prepared with sodium dithionite as reducing agent.
    Vilcek S; Kalincák M; Machán V
    Nuklearmedizin; 1981 Dec; 20(6):283-9. PubMed ID: 6460222
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of source and age of sodium pertechnetate Tc 99m on radiochemical purity of technetium Tc 99m exametazime.
    Millar AM
    Am J Hosp Pharm; 1993 Jan; 50(1):103-6. PubMed ID: 8381258
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of tobacco on the labelling of red blood cells and plasma proteins with technetium-99m.
    Vidal MV; Gutfilen B; da Fonseca LM; Bernardo-Filho M
    J Exp Clin Cancer Res; 1998 Mar; 17(1):41-6. PubMed ID: 9646232
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Failure in labelling of red blood cells with 99mTc: interaction between intravenous cannulae and stannous pyrophosphate.
    Millar AM; Wathen CG; Muir AL
    Eur J Nucl Med; 1983; 8(11):502-4. PubMed ID: 6317393
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sucralose sweetener in vivo effects on blood constituents radiolabeling, red blood cell morphology and radiopharmaceutical biodistribution in rats.
    Rocha GS; Pereira MO; Benarroz MO; Frydman JN; Rocha VC; Pereira MJ; Fonseca AS; Medeiros AC; Bernardo-Filho M
    Appl Radiat Isot; 2011 Jan; 69(1):46-51. PubMed ID: 20801049
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Radiation doses to patients after the use of 99mTc-pyrophosphate and 113mIn-indifor].
    Popov VI; Korsunskiĭ VN; Naumenko AZ; Koval'chuk ND
    Med Radiol (Mosk); 1986 Jul; 31(7):53-7. PubMed ID: 3016453
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Significance of femur and liver radioactivity in relation to quality and fate of phosphate complexes labeled with technetium-99m.
    Hosain P; Hosain F
    Nuklearmedizin; 1976 Apr; 15(2):95-6. PubMed ID: 179062
    [No Abstract]   [Full Text] [Related]  

  • 17. Effect of Thuya occidentalis on the labeling of red blood cells and plasma proteins with technetium-99m.
    Oliveira JF; Braga AC; Avila AS; Fonseca LM; Gutfilen B; Bernardo-Filho M
    Yale J Biol Med; 1996; 69(6):489-94. PubMed ID: 9436292
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of prior administration of Sn(II) complexes on in vivo distribution of 99mTc-pertechnetate.
    Khentigan A; Garrett M; Lum D; Winchell HS
    J Nucl Med; 1976 May; 17(5):380-4. PubMed ID: 1262943
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 99m Tc-EHDP: a potential radiopharmaceutical for skeletal imaging.
    Subramanian G; McAfee JG; Blair RJ; Mehter A; Connor T
    J Nucl Med; 1972 Dec; 13(12):947-50. PubMed ID: 4628825
    [No Abstract]   [Full Text] [Related]  

  • 20. Chemical and in vivo studies of the anion oxo[N,N'-ethylenebis(2-mercaptoacetimido)]Technetate(V).
    Jones AG; Davison A; LaTegola MR; Brodack JW; Orvig C; Sohn M; Toothaker AK; Lock CJ; Franklin KJ; Costello CE; Carr SA; Biemann K; Kaplan ML
    J Nucl Med; 1982 Sep; 23(9):801-9. PubMed ID: 7108629
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.